Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.

Detalhes bibliográficos
Autor(a) principal: Sardi, Janaína de Cássia Orlandi [UNESP]
Data de Publicação: 2016
Outros Autores: Gullo, Fernanda Patrícia [UNESP], Freires, Irlan Almeida, Pitangui, Nayla de Souza [UNESP], Segalla, Maicon Petrônio [UNESP], Fusco-Almeida, Ana Marisa [UNESP], Rosalen, Pedro Luiz, Regasini, Luís Octávio [UNESP], Mendes-Giannini, Maria José Soares [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.diagmicrobio.2016.08.002
http://hdl.handle.net/11449/173724
Resumo: We tested the antifungal potential of caffeic acid and 8 of its derivative esters against Candidaalbicans ATCC 90028 and 9 clinical isolatesand carried out a synergism assay with fluconazole and nystatin. Propyl caffeate (C3) showed the best antifungal activity against the tested strains. When in combination, C3 markedly reduced the MIC of fluconazole and nystatin with synergistic effect up to 64-fold. Finally, C3 showed a high IC50 value and selective indexagainst oral keratinocytes, demonstrating low toxicity against this cell type and selectivity for yeast cells. Further research should confirm its antifungal potential for development of combined therapy to treat C. albicans infections.
id UNSP_7cc926caa269067304e4bfc35c5a41ec
oai_identifier_str oai:repositorio.unesp.br:11449/173724
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.AntifungalCaffeic acidCandida albicansSynergismWe tested the antifungal potential of caffeic acid and 8 of its derivative esters against Candidaalbicans ATCC 90028 and 9 clinical isolatesand carried out a synergism assay with fluconazole and nystatin. Propyl caffeate (C3) showed the best antifungal activity against the tested strains. When in combination, C3 markedly reduced the MIC of fluconazole and nystatin with synergistic effect up to 64-fold. Finally, C3 showed a high IC50 value and selective indexagainst oral keratinocytes, demonstrating low toxicity against this cell type and selectivity for yeast cells. Further research should confirm its antifungal potential for development of combined therapy to treat C. albicans infections.Department of Clinical Analysis Laboratory of Clinical Mycology Faculty of Pharmaceutical Sciences UNESP–Univ Estadual PaulistaDepartment of Biochemistry and Chemical Technology Institute of Chemistry UNESP–Univ Estadual PaulistaDepartment of Physiological Sciences Piracicaba Dental School University of CampinasDepartment of Chemistry and Environmental Sciences Institute of Biosciences Letters and Exact SciencesDepartment of Clinical Analysis Laboratory of Clinical Mycology Faculty of Pharmaceutical Sciences UNESP–Univ Estadual PaulistaDepartment of Biochemistry and Chemical Technology Institute of Chemistry UNESP–Univ Estadual PaulistaUniversidade Estadual Paulista (Unesp)Universidade Estadual de Campinas (UNICAMP)Letters and Exact SciencesSardi, Janaína de Cássia Orlandi [UNESP]Gullo, Fernanda Patrícia [UNESP]Freires, Irlan AlmeidaPitangui, Nayla de Souza [UNESP]Segalla, Maicon Petrônio [UNESP]Fusco-Almeida, Ana Marisa [UNESP]Rosalen, Pedro LuizRegasini, Luís Octávio [UNESP]Mendes-Giannini, Maria José Soares [UNESP]2018-12-11T17:07:27Z2018-12-11T17:07:27Z2016-12-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article387-391application/pdfhttp://dx.doi.org/10.1016/j.diagmicrobio.2016.08.002Diagnostic Microbiology and Infectious Disease, v. 86, n. 4, p. 387-391, 2016.1879-00700732-8893http://hdl.handle.net/11449/17372410.1016/j.diagmicrobio.2016.08.0022-s2.0-849942343782-s2.0-84994234378.pdf0992736452764550Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengDiagnostic Microbiology and Infectious Disease1,157info:eu-repo/semantics/openAccess2024-06-21T15:19:31Zoai:repositorio.unesp.br:11449/173724Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T23:00:01.200123Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
title Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
spellingShingle Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
Sardi, Janaína de Cássia Orlandi [UNESP]
Antifungal
Caffeic acid
Candida albicans
Synergism
title_short Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
title_full Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
title_fullStr Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
title_full_unstemmed Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
title_sort Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
author Sardi, Janaína de Cássia Orlandi [UNESP]
author_facet Sardi, Janaína de Cássia Orlandi [UNESP]
Gullo, Fernanda Patrícia [UNESP]
Freires, Irlan Almeida
Pitangui, Nayla de Souza [UNESP]
Segalla, Maicon Petrônio [UNESP]
Fusco-Almeida, Ana Marisa [UNESP]
Rosalen, Pedro Luiz
Regasini, Luís Octávio [UNESP]
Mendes-Giannini, Maria José Soares [UNESP]
author_role author
author2 Gullo, Fernanda Patrícia [UNESP]
Freires, Irlan Almeida
Pitangui, Nayla de Souza [UNESP]
Segalla, Maicon Petrônio [UNESP]
Fusco-Almeida, Ana Marisa [UNESP]
Rosalen, Pedro Luiz
Regasini, Luís Octávio [UNESP]
Mendes-Giannini, Maria José Soares [UNESP]
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Universidade Estadual de Campinas (UNICAMP)
Letters and Exact Sciences
dc.contributor.author.fl_str_mv Sardi, Janaína de Cássia Orlandi [UNESP]
Gullo, Fernanda Patrícia [UNESP]
Freires, Irlan Almeida
Pitangui, Nayla de Souza [UNESP]
Segalla, Maicon Petrônio [UNESP]
Fusco-Almeida, Ana Marisa [UNESP]
Rosalen, Pedro Luiz
Regasini, Luís Octávio [UNESP]
Mendes-Giannini, Maria José Soares [UNESP]
dc.subject.por.fl_str_mv Antifungal
Caffeic acid
Candida albicans
Synergism
topic Antifungal
Caffeic acid
Candida albicans
Synergism
description We tested the antifungal potential of caffeic acid and 8 of its derivative esters against Candidaalbicans ATCC 90028 and 9 clinical isolatesand carried out a synergism assay with fluconazole and nystatin. Propyl caffeate (C3) showed the best antifungal activity against the tested strains. When in combination, C3 markedly reduced the MIC of fluconazole and nystatin with synergistic effect up to 64-fold. Finally, C3 showed a high IC50 value and selective indexagainst oral keratinocytes, demonstrating low toxicity against this cell type and selectivity for yeast cells. Further research should confirm its antifungal potential for development of combined therapy to treat C. albicans infections.
publishDate 2016
dc.date.none.fl_str_mv 2016-12-01
2018-12-11T17:07:27Z
2018-12-11T17:07:27Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.diagmicrobio.2016.08.002
Diagnostic Microbiology and Infectious Disease, v. 86, n. 4, p. 387-391, 2016.
1879-0070
0732-8893
http://hdl.handle.net/11449/173724
10.1016/j.diagmicrobio.2016.08.002
2-s2.0-84994234378
2-s2.0-84994234378.pdf
0992736452764550
url http://dx.doi.org/10.1016/j.diagmicrobio.2016.08.002
http://hdl.handle.net/11449/173724
identifier_str_mv Diagnostic Microbiology and Infectious Disease, v. 86, n. 4, p. 387-391, 2016.
1879-0070
0732-8893
10.1016/j.diagmicrobio.2016.08.002
2-s2.0-84994234378
2-s2.0-84994234378.pdf
0992736452764550
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Diagnostic Microbiology and Infectious Disease
1,157
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 387-391
application/pdf
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808129480952119296